Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate: In Vivo Investigation in Normal Rabbit Model

Estimating the world cancer burden: Globocan 2000

D. Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · International Journal of Cancer · 2001 · 3.7K citations · Full text

Medicine, Biostatistics, Health Policy +17

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Josep M. Llovet, María Isabel Real, Xavier Montañá et al. · The Lancet · 2002 · 3.5K citations

Medicine, Oncology, Surgery +16

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP

Young Hee Ko, Barbara L. Smith, Yuchuan Wang et al. · Biochemical and Biophysical Research Communications · 2004 · 351 citations

Medicine, Cancer Biology, Oncology +12

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase

Young Hee Ko, Peter L. Pedersen, J.F. Geschwind · Cancer Letters · 2001 · 346 citations

Medicine, Biochemistry, Oncology +16

Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding.

Ernesto Bustamante, Harold P. Morris, Peter L. Pedersen · Journal of Biological Chemistry · 1981 · 324 citations · Full text

Life Sciences, Biochemistry, Oncology +17